Next Article in Journal
A Perilipin Gene from Clonostachys rosea f. Catenulata HL-1-1 Is Related to Sclerotial Parasitism
Previous Article in Journal
Trans-Membrane Area Asymmetry Controls the Shape of Cellular Organelles
Article Menu
Issue 3 (March) cover image

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2015, 16(3), 5334-5346; doi:10.3390/ijms16035334

Comparison of Mutation Profiles in the Duchenne Muscular Dystrophy Gene among Populations: Implications for Potential Molecular Therapies

1
National Medical Centre "20 de Noviembre", Institute for Social Security of State Workers, Mexico City 03100, Mexico
2
Asociación de Distrofia Muscular de Occidente A.C., Guadalajara 44380, Mexico
3
National Institute of Rehabilitation, Mexico City 14389, Mexico
4
Department of Molecular Biology, Panamerican University, Mexico City 03920, Mexico
5
University Center of Exact Sciences and Engineering, University of Guadalajara, Guadalajara 44430, Mexico
6
Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury SP2 8BJ, UK
7
General Hospital of Durango, Durango, 34000, Mexico
8
Instituto de Investigación en Genética Molecular, Centro Universitario de la Ciénega, Universidad de Guadalajara, Ocotlán, 47810, México
9
Department of Human Genetics, Leiden University Medical Center, Leiden 2333 ZA, The Netherlands
10
Studies Section of Postgraduate and Research, School of Medicine, National Polytechnic Institute, Mexico City 11340, Mexico
These authors contributed equally to this work.
*
Author to whom correspondence should be addressed.
Academic Editor: Stephen A. Bustin
Received: 17 December 2014 / Revised: 17 February 2015 / Accepted: 27 February 2015 / Published: 9 March 2015
(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
View Full-Text   |   Download PDF [1469 KB, uploaded 11 March 2015]   |  

Abstract

Novel therapeutic approaches are emerging to restore dystrophin function in Duchenne Muscular Dystrophy (DMD), a severe neuromuscular disease characterized by progressive muscle wasting and weakness. Some of the molecular therapies, such as exon skipping, stop codon read-through and internal ribosome entry site-mediated translation rely on the type and location of mutations. Hence, their potential applicability worldwide depends on mutation frequencies within populations. In view of this, we compared the mutation profiles of the populations represented in the DMD Leiden Open-source Variation Database with original data from Mexican patients (n = 162) with clinical diagnosis of the disease. Our data confirm that applicability of exon 51 is high in most populations, but also show that differences in theoretical applicability of exon skipping may exist among populations; Mexico has the highest frequency of potential candidates for the skipping of exons 44 and 46, which is different from other populations (p < 0.001). To our knowledge, this is the first comprehensive comparison of theoretical applicability of exon skipping targets among specific populations. View Full-Text
Keywords: Ataluren; DMD gene; MLPA; exon skipping; Duchenne; therapies Ataluren; DMD gene; MLPA; exon skipping; Duchenne; therapies
Figures

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

López-Hernández, L.B.; Gómez-Díaz, B.; Luna-Angulo, A.B.; Anaya-Segura, M.; Bunyan, D.J.; Zúñiga-Guzman, C.; Escobar-Cedillo, R.E.; Roque-Ramírez, B.; Ruano-Calderón, L.A.; Rangel-Villalobos, H.; López-Hernández, J.A.; Estrada-Mena, F.J.; García, S.; Coral-Vázquez, R.M. Comparison of Mutation Profiles in the Duchenne Muscular Dystrophy Gene among Populations: Implications for Potential Molecular Therapies. Int. J. Mol. Sci. 2015, 16, 5334-5346.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top